
<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <title>Document Content</title>
    <style>
        body { font-family: Arial, sans-serif; line-height: 1.6; max-width: 900px; margin: auto; padding: 20px; }
        table { border-collapse: collapse; width: 100%; margin-top: 20px; margin-bottom: 20px; }
        th, td { border: 1px solid #cccccc; text-align: left; padding: 8px; font-size: 12px; }
        tr:nth-child(even) { background-color: #f9f9f9; }
        th { background-color: #3366CC; color: white; font-weight: bold; }
        h2 { color: #4F81BD; border-bottom: 2px solid #4F81BD; padding-bottom: 5px;}
        p { margin-block-start: 0.5em; margin-block-end: 0.5em; }
    </style>
</head>
<body>
    <p style="font-size: small; color: grey;"><i>Page 60 of 102</i></p>
<p style="font-size: small; color: grey;"><i>Document</i></p>
<p style="font-size: small; color: grey;"><i>ALIGN-TECHNOLOGY_10k_060.pdf</i></p>
<p>ALIGN TECHNOLOGY, INC. AND SUBSIDIARIES CONSOLIDATED BALANCE SHEETS (in thousands, except per share data)</p>

<table>
	<tr>
		<th rowspan="2"></th>
		<th colspan="2">December 31,</th>
	</tr>
	<tr>
		<th>2017</th>
		<th>2016</th>
	</tr>
	<tr>
		<td>ASSETS</td>
		<td></td>
		<td></td>
	</tr>
	<tr>
		<td>Current assets:</td>
		<td></td>
		<td></td>
	</tr>
	<tr>
		<td>Cash and cash equivalents</td>
		<td>$ 449,511</td>
		<td>$ 389,275</td>
	</tr>
	<tr>
		<td>Marketable securities, short-term</td>
		<td>272,031</td>
		<td>250,981</td>
	</tr>
	<tr>
		<td>Accounts receivable, net of allowance for doubtful accounts and returns of $7,178 and $4,310, respectively</td>
		<td>322,825</td>
		<td>247,415</td>
	</tr>
	<tr>
		<td>Inventories</td>
		<td>31,688</td>
		<td>27,131</td>
	</tr>
	<tr>
		<td>Prepaid expenses and other current assets</td>
		<td>80,948</td>
		<td>38,176</td>
	</tr>
	<tr>
		<td>Total current assets</td>
		<td>1,157,003</td>
		<td>952,978</td>
	</tr>
	<tr>
		<td>Marketable securities, long-term</td>
		<td>39,948</td>
		<td>59,783</td>
	</tr>
	<tr>
		<td>Property, plant and equipment, net</td>
		<td>348,793</td>
		<td>175,167</td>
	</tr>
	<tr>
		<td>Equity method investments</td>
		<td>54,606</td>
		<td>45,061</td>
	</tr>
	<tr>
		<td>Goodwill and intangible assets, net</td>
		<td>89,068</td>
		<td>81,998</td>
	</tr>
	<tr>
		<td>Deferred tax assets</td>
		<td>50,059</td>
		<td>67,844</td>
	</tr>
	<tr>
		<td>Other assets</td>
		<td>38,379</td>
		<td>13,320</td>
	</tr>
	<tr>
		<td>Total assets</td>
		<td>$ 1,777,856</td>
		<td>$ 1,396,151</td>
	</tr>
	<tr>
		<td>LIABILITIES AND STOCKHOLDERS&#x27; EQUITY</td>
		<td></td>
		<td></td>
	</tr>
	<tr>
		<td>Current liabilities:</td>
		<td></td>
		<td></td>
	</tr>
	<tr>
		<td>Accounts payable</td>
		<td>$ 36,776</td>
		<td>$ 28,596</td>
	</tr>
	<tr>
		<td>Accrued liabilities</td>
		<td>194,198</td>
		<td>134,332</td>
	</tr>
	<tr>
		<td>Deferred revenues</td>
		<td>266,842</td>
		<td>191,407</td>
	</tr>
	<tr>
		<td>Total current liabilities</td>
		<td>497,816</td>
		<td>354,335</td>
	</tr>
	<tr>
		<td>Income tax payable</td>
		<td>114,091</td>
		<td>45,133</td>
	</tr>
	<tr>
		<td>Other long-term liabilities</td>
		<td>15,579</td>
		<td>1,294</td>
	</tr>
	<tr>
		<td>Total liabilities</td>
		<td>627,486</td>
		<td>400,762</td>
	</tr>
	<tr>
		<td>Commitments and contingencies (Notes 8 and 9)</td>
		<td></td>
		<td></td>
	</tr>
	<tr>
		<td>Stockholders&#x27; equity:</td>
		<td></td>
		<td></td>
	</tr>
	<tr>
		<td>Preferred stock, $0.0001 par value (5,000 shares authorized; none issued)</td>
		<td>—</td>
		<td>—</td>
	</tr>
	<tr>
		<td>Common stock, $0.0001 par value (200,000 shares authorized; 80,040 and 79,553 issued and outstanding, respectively)</td>
		<td>8</td>
		<td>8</td>
	</tr>
	<tr>
		<td>Additional paid-in capital</td>
		<td>886,435</td>
		<td>864,871</td>
	</tr>
	<tr>
		<td>Accumulated other comprehensive income (loss), net</td>
		<td>571</td>
		<td>(938)</td>
	</tr>
	<tr>
		<td>Retained earnings</td>
		<td>263,356</td>
		<td>131,448</td>
	</tr>
	<tr>
		<td>Total stockholders&#x27; equity</td>
		<td>1,150,370</td>
		<td>995,389</td>
	</tr>
	<tr>
		<td>Total liabilities and stockholders&#x27; equity</td>
		<td>$ 1,777,856</td>
		<td>$ 1,396,151</td>
	</tr>
</table>
<p>The accompanying notes are an integral part of these consolidated financial statements.</p>
<p style="font-size: small; color: grey;"><i>file://usmdcvdi003.us.kworld.kpmg.com/GDC_Ops/Operations/Gayathri%20Krishnan/RPA%20Phase%20II/Kiran/HealthCare/ ... 7/23/2018</i></p>
<p style="font-size: small; color: grey;"><i>60</i></p>

</body>
</html>
